BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29896925)

  • 1. Expression and correlation of MALAT1 and SOX9 in non-small cell lung cancer.
    Chen W; Zhao W; Chen S; Zhang L; Guo Z; Wang L; Wang J; Wan Z; Hong Y; Yu L
    Clin Respir J; 2018 Jul; 12(7):2284-2291. PubMed ID: 29896925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.
    Zhou CH; Ye LP; Ye SX; Li Y; Zhang XY; Xu XY; Gong LY
    J Exp Clin Cancer Res; 2012 Mar; 31(1):18. PubMed ID: 22385677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.
    Lei Z; Shi H; Li W; Yu D; Shen F; Yu X; Lu D; Sun C; Liao K
    Mol Med Rep; 2018 Jan; 17(1):1742-1752. PubMed ID: 29138830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H; Wang J; Liang CF; Zhou T
    Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation.
    Guo F; Guo L; Li Y; Zhou Q; Li Z
    Int J Clin Exp Pathol; 2015; 8(12):15903-10. PubMed ID: 26884862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
    Xie C; Han Y; Liu Y; Han L; Liu J
    Int J Clin Exp Pathol; 2014; 7(10):6534-42. PubMed ID: 25400731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
    BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
    Liu M; Sun W; Liu Y; Dong X
    Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
    Xie C; Han Y; Liu Y; Han L; Liu J
    Int J Clin Exp Pathol; 2014; 7(11):7518-26. PubMed ID: 25550787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
    Tian Y; Feng Y
    Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value.
    Yao JT; Zhao SH; Liu QP; Lv MQ; Zhou DX; Liao ZJ; Nan KJ
    Pathol Res Pract; 2017 May; 213(5):453-456. PubMed ID: 28343871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.